Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

Bernhard Englinger, Anna Laemmerer, Patrick Moser, Sebastian Kallus, Clemens Roehrl, Christine Pirker, Dina Baier, Thomas Mohr, Laura Niederstaetter, Samuel M. Meier-Menches, Christopher Gerner, Lisa Gabler, Johannes Gojo, Gerald Timelthaler, Julia Senkiv, Walter Jaeger, Christian R. Kowol, Petra Heffeter, Walter Berger (Corresponding author)

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)1680-1693
Number of pages14
JournalInternational Journal of Cancer
Volume147
Issue number6
DOIs
Publication statusPublished - 2 Mar 2020

Austrian Fields of Science 2012

  • 301904 Cancer research
  • 104002 Analytical chemistry
  • 301206 Pharmacology

Keywords

  • Ponatinib
  • lipid droplets
  • resistance
  • cancer
  • drug sequestration
  • BREAST-CANCER CELLS
  • ACCUMULATION
  • ROLES

Fingerprint

Dive into the research topics of 'Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib'. Together they form a unique fingerprint.

Cite this